Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06595407

Loss of Y Chromosome in Aortic Stenosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
Male
Age
40 Years
Healthy volunteers
Accepted

Summary

The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in 2-3% of adults over 65 years of age and when it progresses to a severe stage leads to heart failure and need for valve replacement procedures (including surgery and catheter-based replacement). Aortic stenosis has a strong male predominance. The purpose of this study is to evaluate whether loss of Y-chromosome from circulating blood cells in males, which has been associated with TGF-beta-related fibrosis of other organs, is associated with the development of aortic stenosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood analysis for loss-of-Y chromosomeAnalysis for the percentage of circulating leukocytes with loss-of-y chromosome

Timeline

Start date
2024-08-15
Primary completion
2025-12-31
Completion
2026-06-01
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06595407. Inclusion in this directory is not an endorsement.

Loss of Y Chromosome in Aortic Stenosis (NCT06595407) · Clinical Trials Directory